精神科实践中的丙戊酸钠:是时候改变认知了
本文指出丙戊酸钠因对胎儿的潜在影响及医生风险沟通不足而受到监管审查,但其问题不止于此。精神科存在基于「使用便捷等同于更安全」的错误认知而过度使用丙戊酸钠的现象,丙戊酸可能干扰基本生理过程,其后果在精神科文献中鲜有讨论。丙戊酸钠可能对少数双相障碍患者有用,但当前处方模式缺乏合理性,亟需改变认知。
要点
- 丙戊酸钠在精神科被过度使用,源于「使用便捷即更安全」的错误认知。
- 丙戊酸可能干扰基本生理过程,其后果在精神科文献中了解甚少且鲜有讨论。
- 丙戊酸钠可能对少数双相障碍患者有用,但当前处方模式不合理。
核心结论
- 精神科对丙戊酸钠的认知需要改变,当前处方模式缺乏合理性。
研究设计与样本
- 本文为评论文章,基于监管审查背景讨论丙戊酸钠在精神科的使用问题。
主要发现
- 丙戊酸钠因对胎儿的担忧及医生风险沟通不足而受到监管审查。
- 精神科过度使用丙戊酸钠基于「使用便捷等同于更安全」的错误认知。
- 丙戊酸可能干扰基本生理过程,其后果在精神科文献中了解甚少。
关键数值与推荐
- 丙戊酸钠可能对少数双相障碍患者有用,但当前处方模式不合理。
临床怎么用
- 精神科医生应改变对丙戊酸钠的认知,重新评估其处方模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Sodium valproate and related preparations have recently undergone regulatory review following concern about effects on the unborn child and doctors' failure to communicate risk. The issues are wider. Valproate is overused in psychiatry based on the false perception that 'ease' of use equates to better safety than alternatives. Valproic acid can disrupt fundamental physiological processes, the consequences of which are poorly understood and little discussed in the psychiatric literature. Valproate may be useful in a small number of patients with bipolar disorder but current prescribing patterns are unjustified. Perception needs to change. DECLARATION OF INTEREST: D.C.O. is psychiatric commissioner on the Commission on Human Medicines and a member of the European Medicines Agency's Scientific Advisory Group on Psychiatry. He chaired the European Medicines Agency's review of the psychiatric use of valproate in pregnancy and women of childbearing potential.
引用
- Owens DC. Sodium valproate in psychiatric practice: time for a change in perception. Br J Psychiatry. 2019. PMID: 31190658. doi:10.1192/bjp.2019.137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。